xortx.com (XRTX) - Bozor qiymatining balans qiymatiga nisbati
XORTX Therapeutics Inc. (XRTX) aktivlari YaIM yoki mavsumiylik ta'siriga duch kelmaydi, bu esa yuqori makro-barqarorlikni ta'minlaydi. Kompaniyaning bozor qiymatining buxgalteriya qiymatiga nisbati tebranishlarni namoyon etmoqda va ushbu ko'rsatkich hozirda 0.33 darajasida turibdi. Muntazam daromad yo'qligi sababli joriy barqarorlik investitsiyalarni jalb qilishga bog'liq, uzoq muddatli o'sish esa buyrak terapiyasi uchun noyob formulalarning patent himoyasiga asoslangan.
XORTX Therapeutics Inc (XRTX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati XORTX Therapeutics Inc.|XRTX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati XORTX|XRTX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar XORTX|XRTX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari XORTX Therapeutics|Tezkor likvidlik koeffitsiyenti xortx.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning asosiy tahlili:XORTX Therapeutics Inc. - XRTX
Uzoq muddatli aktivlarni skrining qilish bozor kotirovkalari va moliyaviy hisobotlarning sintezini talab qiladi. Ushbu ko'rsatkich kapitalning haddan tashqari qimmat baholanganligi yoki past baholanganlik darajasini aniqlash uchun kompaniyaning bozor qiymatini uning sof aktivlari bilan solishtiradi. Buyrak kasalliklari uchun innovatsion dori vositalarini ishlab chiqayotgan XORTX Therapeutics Inc. (XRTX) uchun ushbu farq bozorning kelajakdagi yutuqlarga bo'lgan kutganlarini aks ettiradi. Investor biznes istiqbollari dinamikasini narxning buxgalteriya qiymatiga nisbati orqali kuzatishi mumkin.
Raqobatchilar tahlili
ARGX (argenx SE) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati BNTX|Bozor qiymatining balans qiymatiga nisbati abivax.com|ADMA Biologics Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati PTGX|IMVT (Immunovant Therapeutics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|Bozor kapitallashuvining balans qiymatiga nisbati grifols.com GRFS|ADPT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com|Kapitallashuvning sof aktivlarga nisbati PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TRML (Tourmaline Corp)|Balans qiymatiga nisbatan bozor kapitallashuvi Precigen Corp (PGEN)|PHAR - Bozor qiymatining balans qiymatiga nisbati|nektar.com (NKTR) - Kapitallashuvning sof aktivlarga nisbati|Upstream Bio (UPB) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|Kapitallashuvning sof aktivlarga nisbati IMNM|Bozor kapitallashuvining balans qiymatiga nisbati Gossamer Bio Corp.|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals (KALV)|septerna.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|RIGL: Kapitallashuvning sof aktivlarga nisbati|ANAB (AnaptysBio Inc.) - Kapitallashuvning balans qiymatiga nisbati|Astria Therapeutics (ATXS) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti engene.com (ENGN)|Bozor qiymatining balans qiymatiga nisbati RAPT Therapeutics|JBIO: Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati ACRS (Aclaris)|Bozor kapitallashuvining balans qiymatiga multiplikatori KYTX|Tiziana Life Sciences - Kapitallashuvning sof aktivlarga nisbati|CABA: Kapitallashuvning balans qiymatiga nisbati|VTYX: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati THTX (Theratechnologies, Inc.)|AVTX (Avalo Therapeutics Inc.) - Kapitallashuvning sof aktivlarga nisbati|ELDN: Bozor kapitallashuvining balans qiymatiga multiplikatori|AGEN (Agenus) - Bozor kapitallashuvining balans qiymatiga nisbati|CLYM: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ZURA|ATYR - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Adagene Inc. ADAG|Balans qiymatiga nisbatan bozor qiymati IMA|Shattuck Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|EQ - Bozor kapitallashuvining balans qiymatiga nisbati|connectbiopharm.com (CNTB) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi IMUX (Immunic)|ATRA (Atara Biotherapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti InflaRx GmbH IFRX|Kapitallashuvning sof aktivlarga nisbati XFOR (X4 Pharmaceuticals)|Bozor kapitallashuvining balans qiymatiga nisbati adicetbio.com (ACET)|Celularity - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori INMB (INmune Bio Inc)|Barinthus Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Kezar Life Sciences Inc KZR|SABS: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati akaritx.com|Bozor qiymatining balans qiymatiga nisbati Enlivex Therapeutics Ltd|Q32 Bio Corp (QTTB) - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati GOVX (GeoVax Labs Inc)|EDSA (Edesa Biotech Corp) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati IBIO (iBio, Inc.)|Balans qiymatiga nisbatan bozor kapitallashuvi Carisma Therapeutics Inc (CARM)|XTLB - Bozor qiymatining balans qiymatiga nisbati|BOLT (Bolt Biotherapeutics) - Kapitallashuvning balans qiymatiga nisbati|HCWB: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Aptevo Therapeutics Inc.|Kapitallashuvning sof aktivlarga nisbati AIM|Aditxt Corp (ADTX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati GRI (GRI Bio)|Vyome Holdings Inc. - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Revelation Bio REVB|Balans qiymatiga nisbatan bozor qiymati INDP|SCNI: Kapitallashuvning sof aktivlarga nisbati|CalciMedica, Inc. - Bozor kapitallashuvining balans qiymatiga multiplikatori|AFMD (affimed.com) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati ALLK|Bozor qiymatining balans qiymatiga nisbati HOOKIPA Pharma, Inc.|IGM Bio - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ITOS|OCEA (oceanbiomedical.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TCBP (TC BioPharm)|Bozor kapitallashuvining balans qiymatiga nisbati Third Harmonic Bio Inc. THRD